Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Europe (Primary) | PRIMARYEUR | Univ | 6,266 | 19,759,712 | 0.16% | 1.30% | 0.56% | 1.88% | 2.62% | 10.21% |
Healthcare | HEALTHCARE | Sector | 577 | 2,047,939 | 0.41% | 0.24% | -2.97% | -1.20% | -10.14% | -17.64% |
Biopharmaceuticals | BIOPHARMA | SubSec | 184 | 1,549,359 | 0.24% | 0.24% | -3.79% | -0.86% | -11.63% | -23.21% |
Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 55 | 33,673 | 1.44% | -1.66% | 4.05% | 8.24% | -3.52% | -10.97% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 12 | 4,962 | 1.41% | 0.72% | 28.87% | 35.91% | 25.85% | -7.78% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Valneva SE | VLA:FRAVLA:FRA | Stock | 1 | 750 | 8.74% | 17.59% | 51.42% | 37.91% | 6.97% | 16.76% |
Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 2,892 | 0.13% | -0.59% | 31.91% | 42.60% | 35.40% | 25.93% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 12 | 4,962 | 1.41% | 0.72% | 28.87% | 35.91% | 25.85% | -7.78% |
Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 778 | 0.00% | -7.18% | 7.26% | 18.58% | 26.87% | 35.87% |
Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,266 | 19,759,712 | 0.18% | 1.17% | 0.01% | -0.13% | 0.41% | 9.48% |
* Colors indicate performance relative to the benchmark.